October 30, 2013
The reorganized K-V Pharmaceutical Co. on Tuesday reached a $5 million settlement with a group of senior secured lenders who had sued to obtain $34.7 million in additional interest on the debt they held.
August 28, 2013
A New York federal bankruptcy judge Wednesday approved a settlement in which K-V Discovery Solutions Inc. will pay roughly $23.8 million to settle a False Claims Act suit and pay for accompanying fines, shortly after K-V received the go-ahead for its Chapter 11 restructuring plan.
August 28, 2013
K-V Pharmaceutical Co. on Wednesday received a bankruptcy judge's approval of its reorganization plan that will allow it to exit the Chapter 11 process and continue its business following a competitive bidding process.
August 19, 2013
Creditors of K-V Pharmaceutical Co. on Friday urged a New York bankruptcy judge to deny a group of senior bondholders' demand for post-petition interest on the debt they hold before convertible noteholders receive any payments.
July 16, 2013
K-V Pharmaceutical Co. can now begin soliciting creditor votes for its Chapter 11 restructuring plan after receiving the go-ahead from a New York bankruptcy judge Tuesday and months of bouncing back and forth between two competing groups of interested investors.
July 08, 2013
Silver Point Finance LLC and other senior noteholders in K-V Pharmaceutical Co.'s bankruptcy on Wednesday urged a New York bankruptcy judge to force the company to pay millions in accrued interest on a group of senior bonds.
June 07, 2013
The bidding war for K-V Pharmaceutical Co. drew to a close Friday as a New York bankruptcy judge approved a plan support agreement with a group of investors offering a $275 million plan to take over the women's health company and finance its exit from bankruptcy.
May 31, 2013
A group of senior bondholders led by Silver Point Finance LLC on Friday upped their offer to take control of the bankrupt K-V Pharmaceutical Co. in response to a group of investors that raised the stakes by increasing their own proposal just days ago.
May 29, 2013
An investor group that has proposed a Chapter 11 plan that would allow it to take over K-V Pharmaceutical Co. upped its proposal to $275 million on Wednesday in New York bankruptcy court, once again raising the stakes for a group of senior bondholders who first sought to take over the company.
May 29, 2013
K-V Pharmaceutical Co. has agreed to hand Texas a $3 million unsecured claim in its bankruptcy to settle a whistleblower suit alleging the company made false claims to the state's Medicaid program, according to court documents filed Tuesday.